Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis.
Liver X Receptors differentially modulate central myelin gene mRNA levels in a region-, age- and isoform-specific manner.
Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.
Role of Vitamin D in the Onset, Progression and Severity of Multiple Sclerosis.
Prevalence of temporomandibular disorders symptoms in patients with multiple sclerosis.
Intrinsic and extrinsic control of oligodendrocyte development.
High-mobility group box 1 in multiple sclerosis.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
Vascular pathology of multiple sclerosis.
Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
[New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimode].
Atorvastatin: Multiple Sclerosis.
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
[Anti-MOG antibody in different types of immune-mediated optic neuritis].
A wireless body measurement system to study fatigue in multiple sclerosis.
Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection.
Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.
Evaluation of Inner Retinal Layers in Patients with Multiple Sclerosis or Neuromyelitis Optica Using Optical Coherence Tomography.
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse.
The specific antigen approach in multiple sclerosis: Can it ever be enough?
Perth scientists embark on stroke therapy approach
Biomechanical disorders of foot in multiple sclerosis.
Fluoxetin Upregulates Connexin 43 Expression in Astrocyte.
Mild phenotype of Charcot-Marie-Tooth disease type 4B1.
Pages
« first
‹ previous
…
274
275
276
277
278
279
280
281
282
…
next ›
last »